ArticleBMC geriatrics2025
The prevalence and etiology of anemia and the association between anemia and all-cause mortality: a cohort study over a 9-year period.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anemia, iron deficiency, and blood biomarkers for Alzheimer disease: clinical interpretation and dementia risk stratification.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
RESEARCH
backgroundAs the global population ages rapidly, anemia prevalence rises among older adults, yet its impact on quality of life and mortality in this group remains poorly understood. This study aimed to identify risk factors for anemia and examine its associations with quality of life and 9-year all-cause mortality among Chinese adults aged ≥60.
methodsWe evaluated the determinants and consequences of anemia in 5,050 participants aged ≥ 60 from the China Health and Retirement Longitudinal Study (CHARLS), a prospective cohort of community-dwelling elderly individuals ≥ 45 at baseline and followed for up to 9 years. Anemia was defined according to the World Health Organization criteria. Multinomial logistic regression was performed to assess the correlation between anemia and aging. Cox proportional hazards models were used to evaluate the impact of anemia on all-cause mortality.
resultsIn 2011, anemia prevalence was 15.05% (95% CI, 14.00–16.06%) and increased with age. Age (OR, 1.03; 95% CI, 1.01–1.05; P < 0.01), living in rural areas (OR, 1.51; 95% CI, 1.18–1.92; P < 0.01), and hypoproliferation ((OR, 1.43; 95% CI, 1.12–1.83; P < 0.01) were positively associated with anemia.Negative associations were observed for higher hematocrit (OR, 0.93; 95% CI, 0.91–0.95; P < 0.01) , total cholesterol (OR, 1.00; 95% CI, 0.99–1.00; P = 0.03), and the creatinine clearance rate (OR, 0.99; 95% CI, 0.98–1.00; P < 0.01). During the 9 years of follow-up, 741 of the 4767 (15.54%) participants died. After adjusting for covariates, anemia remained independently associated with mortality (HR, 1.22, 95% CI, 1.02, 1.47; P=0.03) was still closely associated with mortality. Persistent anemia significantly impaired survival, and anemia was linked to reduced quality of life.
conclusionThis study revealed that anemia is prevalent among individuals aged ≥ 60 years in China and is related to age, residence type, hypoproliferation, hematocrit, total cholesterol and the creatinine clearance rate. Research has also confirmed that anemia is associated with worse overall survival in Chinese older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.